UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (29) 29
oncology (26) 26
life sciences & biomedicine (25) 25
humans (21) 21
breast cancer (20) 20
female (20) 20
aged (11) 11
breast neoplasms - drug therapy (11) 11
cancer (11) 11
middle aged (11) 11
breast neoplasms - pathology (10) 10
medicine & public health (8) 8
tumors (8) 8
adult (7) 7
aged, 80 and over (7) 7
breast neoplasms - metabolism (7) 7
fulvestrant (7) 7
metastasis (7) 7
animals (6) 6
breast neoplasms - genetics (6) 6
cell line, tumor (5) 5
drug resistance (5) 5
estrogens (5) 5
genes (5) 5
neoplasm metastasis (5) 5
neoplasm staging (5) 5
receptors, estrogen - metabolism (5) 5
biomarkers, tumor (4) 4
cancer research (4) 4
chemotherapy (4) 4
deoxyribonucleic acid--dna (4) 4
erbb-2 protein (4) 4
gene expression (4) 4
gene sequencing (4) 4
inhibitors (4) 4
metastases (4) 4
mice (4) 4
multidisciplinary sciences (4) 4
mutation (4) 4
patients (4) 4
receptor, erbb-2 - metabolism (4) 4
research (4) 4
science & technology - other topics (4) 4
treatment outcome (4) 4
adjuvant treatment (3) 3
amplification (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
breast neoplasms - mortality (3) 3
care and treatment (3) 3
cell biology (3) 3
chemotherapy, adjuvant (3) 3
clinical trials (3) 3
development and progression (3) 3
disease-free survival (3) 3
drug resistance, neoplasm (3) 3
drug resistance, neoplasm - genetics (3) 3
estrogen receptors (3) 3
fulvestrant - administration & dosage (3) 3
hematology, oncology and palliative medicine (3) 3
immunohistochemistry (3) 3
postmenopause (3) 3
prognosis (3) 3
protein kinase inhibitors - pharmacology (3) 3
skin and connective tissue diseases (3) 3
spain - epidemiology (3) 3
surgery (3) 3
tyrosine (3) 3
xenograft model antitumor assays (3) 3
1-phosphatidylinositol 3-kinase (2) 2
analysis (2) 2
antagonists (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
antineoplastic agents (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
aromatase (2) 2
aromatase inhibitors - therapeutic use (2) 2
breast neoplasm (2) 2
breast neoplasms - epidemiology (2) 2
breast neoplasms - surgery (2) 2
cancer epidemiology (2) 2
cell proliferation (2) 2
conversion (2) 2
cyclin-dependent kinase 4 (2) 2
deprivation (2) 2
diagnosis (2) 2
disease models, animal (2) 2
disease progression (2) 2
dna sequencing (2) 2
drug resistance, neoplasm - drug effects (2) 2
drug therapy (2) 2
estrogen receptor alpha - metabolism (2) 2
experimental design (2) 2
fibroblast growth factor receptor 1 (2) 2
fibroblast growth factor receptors (2) 2
gene expression regulation, neoplastic (2) 2
genetic aspects (2) 2
her2 (2) 2
kaplan-meier estimate (2) 2
ligands (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 367 - 377
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 2/2014, Volume 143, Issue 3, pp. 507 - 515
Journal Article
Journal Article
Nature communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 1373 - 1373
Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Cyclin D1 - metabolism | Receptors, Estrogen - metabolism | Circulating Tumor DNA - genetics | Humans | Purines - administration & dosage | Fulvestrant - pharmacology | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Quinolines - pharmacology | Breast Neoplasms - metabolism | Quinoxalines - pharmacology | MCF-7 Cells | Fulvestrant - administration & dosage | Female | Receptor, Fibroblast Growth Factor, Type 2 - antagonists & inhibitors | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Pyrazoles - pharmacology | Aminopyridines - administration & dosage | Antineoplastic Agents, Hormonal - pharmacology | Signal Transduction | Purines - pharmacology | Antineoplastic Agents, Hormonal - administration & dosage | Proportional Hazards Models | Breast Neoplasms - drug therapy | Piperazines - pharmacology | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Naphthalenes - pharmacology | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aminopyridines - pharmacology | Progression-Free Survival | High-Throughput Nucleotide Sequencing | Mice | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Mutation | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Drug Resistance, Neoplasm - drug effects | Tyrosine | Xenotransplantation | Clinical trials | Antagonists | Breast cancer | Drug resistance | Patients | Cyclin-dependent kinase 4 | Fulvestrant | Gene sequencing | Amplification | Next-generation sequencing | Inhibitors | Xenografts | Open reading frames | Fibroblast growth factor receptor 1 | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | DNA sequencing | Cancer | Fibroblast growth factor receptors | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 10/2017, Volume 23, Issue 20, pp. 6138 - 6151
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Gene Expression Regulation, Neoplastic | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Fibroblast Growth Factors - genetics | Molecular Targeted Therapy | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Estrogen Receptor alpha - metabolism | Female | Transcription, Genetic | Disease Models, Animal | Estrogen Receptor alpha - antagonists & inhibitors | Breast Neoplasms - drug therapy | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Estrogen Receptor Modulators - pharmacology | Protein Transport | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Gene Amplification | Signal Transduction - drug effects | Breast Neoplasms - pathology | Cell Line, Tumor | Mice | Protein Kinase Inhibitors - pharmacology | Neoplasm Staging | Cell proliferation | Fibroblast growth factor | Transcription | Genes | Estrogens | Estrogen receptors | Antagonists | Kinases | Nuclei | Fulvestrant | Gene sequencing | E2F protein | Surgery | Xenografts | Inhibition | Fibroblast growth factor receptor 1 | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | Binding | Tyrosine | Deprivation | Breast cancer | siRNA | Gene expression | Ribonucleic acid--RNA | Patients | Polymerase chain reaction | Amplification | Experimental design | Ligands | Nuclei (cytology) | Tumors | Cancer | Fibroblast growth factor receptors | Index Medicus | breast cancer | drug resistance | fulvestrant | FGFR1
Journal Article